In the present study, it is similarly demonstrated that TGIF1 can significantly affect the proliferative capacity of gliomas, suggesting that TGIF1 serves as a clearly therapeutic target to inhibit glioma proliferation. This evidence concerns the gene TGIF1 and central nervous system cancer.